These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8517688

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study.
    Ghosh R, Das S, De A, Kela H, Saha ML, Maiti PK.
    Int J Mycobacteriol; 2017; 6(1):34-37. PubMed ID: 28317802
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
    Van der Auwera P, Klastersky J.
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1061-8. PubMed ID: 3116918
    [Abstract] [Full Text] [Related]

  • 26. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS, Chang SC, Shen EP, Hu FR.
    PLoS One; 2015 Jul; 10(1):e0116236. PubMed ID: 25581038
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
    Dalovisio JR, Pankey GA, Wallace RJ, Jones DB.
    Rev Infect Dis; 1981 Jul; 3(5):1068-74. PubMed ID: 7339806
    [Abstract] [Full Text] [Related]

  • 29. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
    Wallace RJ, Swenson JM, Silcox VA, Bullen MG.
    J Infect Dis; 1985 Sep; 152(3):500-14. PubMed ID: 3875667
    [Abstract] [Full Text] [Related]

  • 30. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans.
    Thangaraj HS, Adjei O, Allen BW, Portaels F, Evans MR, Banerjee DK, Wansbrough-Jones MH.
    J Antimicrob Chemother; 2000 Feb; 45(2):231-3. PubMed ID: 10660507
    [Abstract] [Full Text] [Related]

  • 32. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
    Rastogi N, Goh KS, Bryskier A.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA, Gomez Garcia AC.
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [Abstract] [Full Text] [Related]

  • 35. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R, Cockrum P, Crider J, Schlech B.
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H, Nakajima H, Kaminaga Y.
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.